peripheral blood
-
not specified
RNA-seq; RT-qPCR; Clinical Sample Validation; Survival Analysis
OS was correlated with circCDK14 (P-value < 0.1) in univariate analysis
circCDK14(3-4) is increased in CLL compared with healthy B cells, and shows a stronger upregulation in the t(14;19) CLL subgroup; it is among validated circRNAs included in survival analysis.
0.4679
Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study.
combined biological and clinical study